NASDAQ

RenovoRx Inc

1.33
RNXT医療関連
  • 15分ディレイ株価
前日比
+0.01(+0.76%)

RenovoRx Incの株価・株式情報

株価詳細値

マネックス証券ロゴこの銘柄はマネックス証券で
期間を保存

企業概要

RenovoRx is a clinical-stage biopharmaceutical company focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for its lead product candidate RenovoGem™. Co.'s therapy platform, RenovoRx Trans-Arterial Micro-Perfusion, or RenovoTAMP™ utilizes approved chemotherapeutics with validated mechanisms of action and well-established safety and side effect profiles, with the goal of increasing their efficacy, improving their safety, and widening thei

参考指標

  • 時価総額
    13,475.00千ドル(03/18)
  • 発行済株式数
    10,131,798(03/19)
  • PER(実績)
    ---(--:--)
  • PBR(実績)
    ---(--:--)
  • EPS(実績)
    ---(----/--)
  • BPS(実績)
    ---(----/--)
  • 52週高値
    4.60(23/03/30)
  • 52週安値
    0.53(23/12/06)